Faster the Heart Pulse, Higher the Future Risk of Diabetes: Penn State Research

In a four-year study, Penn State researchers observed that faster heart rates were positively associated with an increased risk of developing diabetes.

A person's risk of diabetes can be determined by evaluating the heart rate, suggests a new study linking heart rate and diabetes.

In a four-year study of 73,357 Chinese adults, Penn State researchers observed that faster heart rates were positively associated with an increased risk of developing diabetes.

India's Large-Scale Screening for Diabetes Has Been Predicted to be Ineffective
Large number of false positive results from the widespread use of diabetes screening tests in India are resulting in the wastage of $169 to $567 million.

Researchers also found that faster heart rates were associated with impaired fasting glucose levels and a conversion from impaired fasting glucose levels to diabetes among the same population.

Senior author Xiang Gao said that they found participants with faster heart rates, suggesting lower automatic function, had increased risk of diabetes, pre-diabetes and conversion from pre-diabetes to diabetes.

Gao added that each additional 10 beats per minute was associated with 23% increased risk of diabetes, similar to the effects of a 3 kilogram per meter square increase in body mass index.

Early Diagnosis and Treatment of Type 2 Diabetes Reduces Risk of Heart Disease, Death
A delay of three years in diagnosis and treatment of type 2 diabetes increases the risk of cardiovascular diseases by 22.4%.

He added that this suggests that faster heart rate could be a novel pre-clinical marker or risk factor for diabetes.

The study is published in the International Journal of Epidemiology.

Eat Four Eggs a Week to Reduce Risk of Type 2 Diabetes by 40 Percent
The nutrients in eggs may help improve the way the body metabolizes sugar and help to decrease inflammation that cause chronic illness.

Source-ANI

Diabetes Drug may Curb Heart Attack Risk in Patients Infected by Human Immunodeficiency Virus
The diabetes drug sitagliptin (brand name Januvia) both improved metabolism and reduced inflammation in HIV-positive adults taking antiretroviral therapy.